Reports on immune-related events after COVID-19 vaccination in autoimmune patients mainly focused on the immediate phenotypes in the small samples, and few studies gave real-world evidence on changes of inflammatory or hormone changes of AID, which were shown to predict future outcomes in a number of chronic conditions (25, 26). This evidence concerns the gene AICDA and COVID-19.